Related Experiment Videos
Hyperammonemia after high-dose chemotherapy and stem cell transplantation
P Frere1, J L Canivet, C Gennigens
1Department of Medicine, University of Liège, Belgium.
Bone Marrow Transplantation
|September 1, 2000
Summary
A rare but dangerous syndrome, hyperammonemia, can occur after stem cell transplants in multiple myeloma patients. Early recognition and treatment of this neurological complication are crucial for survival and recovery.
Area of Science:
- Hematology
- Neurology
- Oncology
Background:
- Multiple myeloma is a hematologic malignancy.
- Stem cell autografts are a common treatment for multiple myeloma.
- Hyperammonemia is a rare but serious complication post-transplant.
Observation:
- A patient with multiple myeloma developed hyperammonemia after a second stem cell autograft.
- The patient presented with confusion and neurological degradation.
- Respiratory alkalosis was noted on clinical examination.
Findings:
- Hyperammonemia post-stem cell autograft is a poorly recognized syndrome.
- This syndrome is associated with a high mortality rate.
- Prompt diagnosis and treatment led to full recovery in this patient.
Implications:
- Considering hyperammonemia in patients with neurological decline after chemotherapy is vital.
- Early diagnosis and intervention can improve patient survival rates.
- Further research into mechanisms and therapies for post-transplant hyperammonemia is warranted.